City
Epaper

DGCI approves for phase III trial of Bharat Biotech intranasal vaccine as booster

By IANS | Updated: January 5, 2022 13:05 IST

New Delhi, Jan 5 The Subject Experts Committee (SEC) of the Drug Controller General of India (DGCI) on ...

Open in App

New Delhi, Jan 5 The Subject Experts Committee (SEC) of the Drug Controller General of India (DGCI) on Wednesday granted "in principle" approval to Bharat Biotech to conduct "Phase III superiority study and Phase III booster dose study" trials for its intranasal Covid vaccine.

The approval was sought by the vaccine manufacturer last week.

The SEC has asked the company to submit the protocol for booster study.

On Tuesday, the Committee held a meeting to discuss the vaccine manufacturer Bharat Biotech's application for clinical trials of its intranasal Covid vaccine as a booster.

The Hyderabad-based manufacturer had proposed the booster dose for those who have been already been innoculated with Covishield and Covaxin vaccines.

According to a source, Bharat Biotech aims to conduct clinical trials on 5,000 healthy subjects: half or 2,500 individuals who have received Covishield and another 2,500 who have been administered Covaxin.

There will be a gap of around six months between the second and the intranasal booster dose. The source said that the nasal booster vaccine is likely to be launched in India by March following clinical trials.

In his address to the nation on December 25, Prime Minister Narendra Modi had assured that soon the country will develop a nasal vaccine.

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: New DelhiindiaSECBharat biotechNarendra Modi
Open in App

Related Stories

NationalJP Nadda Announces Maharashtra Governor CP Radhakrishnan as NDA’s Nominee for Vice President of India

NationalIndependence Day 2025: 'Start-ups in Tier-2 & Tier-3 Cities Contribute to Country’s Economic Strength & Innovation,' Says PM Narendra Modi

NationalIndependence Day 2025: ‘Atmanirbhar is Directly Connected to Our Strength’ Says PM Narendra Modi (Watch Video)

EntertainmentZara Khan Urges Supreme Court to Reconsider Order on Removing Stray Dogs from Delhi-NCR

TechnologyHow To Effortlessly Transfer Data from Android to iPhone Using Apple’s Move to iOS App

Health Realted Stories

HealthGenetic evidence confirms early puberty accelerates ageing, disease: Study

HealthMonsoon Health: Early Dengue Symptoms in Children Parents Should Not Ignore

HealthRajasthan: 5 doctors, 4 employees suspended at RGHS; FIR filed against hospital

HealthAhmedabad to set up first CNG-powered dog crematorium as a part of animal welfare

HealthHerbal tobacco cessation products unregulated on Amazon, Flipkart, Blinkit: ICMR study